BioCrete ApS: Financial statements 2023
CVR: 41353430
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
BioCrete ApS (CVR 41353430) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -277,750 and a net result of DKK -286,192 compared with DKK -758,126 the year before. Equity in the 2023 report amounted to DKK 141,844. The solvency ratio was 94.7%.
- Gross Profit
- DKK -277,750
- Profit/Loss
- DKK -286,192
- Equity
- DKK 141,844
- Total Assets
- DKK 149,844
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -278 t. | -286 t. | 142 t. | - |
| 2022 | - | 590 t. | -758 t. | 428 t. | - |
| 2021 | - | 1.1 mio. | 1 mio. | 1.2 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
BioCrete ApS has published its annual report for 2022. Gross profit came to DKK 589,571, and the net result was DKK -758,126.
About BioCrete ApS
BioCrete ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2020. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Lasse Nørbye Døssing. The company's owners include CemGreen ApS, COPAseed A/S and Sean Crowe Holdings Ltd.. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -23,990 and a net result of DKK -33,465 compared with DKK -26,885 the year before. Equity in the 2025 report amounted to DKK 81,495.